25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Arcellx Inc
Buy, Hold or Sell?

Let's analyze Arcellx together

I guess you are interested in Arcellx Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Arcellx Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Arcellx Inc

I send you an email if I find something interesting about Arcellx Inc.

1. Quick Overview

1.1. Quick analysis of Arcellx (30 sec.)










1.2. What can you expect buying and holding a share of Arcellx? (30 sec.)

How much money do you get?

How much money do you get?
$1.50
When do you have the money?
1 year
How often do you get paid?
12.5%

What is your share worth?

Current worth
$8.93
Expected worth in 1 year
$12.94
How sure are you?
31.3%

+ What do you gain per year?

Total Gains per Share
$5.51
Return On Investment
6.4%

For what price can you sell your share?

Current Price per Share
$85.85
Expected price per share
$75.10 - $107.37
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Arcellx (5 min.)




Live pricePrice per Share (EOD)
$85.85
Intrinsic Value Per Share
$4.72 - $5.66
Total Value Per Share
$13.65 - $14.59

2.2. Growth of Arcellx (5 min.)




Is Arcellx growing?

Current yearPrevious yearGrowGrow %
How rich?$483m$267.1m$220.9m45.3%

How much money is Arcellx making?

Current yearPrevious yearGrowGrow %
Making money-$10.1m-$32.2m$22.1m219.6%
Net Profit Margin-46.4%-145.2%--

How much money comes from the company's main activities?

2.3. Financial Health of Arcellx (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#133 / 949

Most Revenue
#154 / 949

Most Profit
#559 / 949

Most Efficient
#390 / 949
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Arcellx?

Welcome investor! Arcellx's management wants to use your money to grow the business. In return you get a share of Arcellx.

First you should know what it really means to hold a share of Arcellx. And how you can make/lose money.

Speculation

The Price per Share of Arcellx is $85.85. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Arcellx.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Arcellx, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $8.93. Based on the TTM, the Book Value Change Per Share is $1.00 per quarter. Based on the YOY, the Book Value Change Per Share is $0.14 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.38 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Arcellx.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.48-0.6%-0.19-0.2%-0.60-0.7%-0.46-0.5%-0.46-0.5%
Usd Book Value Change Per Share-0.08-0.1%1.001.2%0.140.2%0.560.7%0.560.7%
Usd Dividend Per Share0.000.0%0.380.4%0.000.0%0.090.1%0.090.1%
Usd Total Gains Per Share-0.08-0.1%1.381.6%0.140.2%0.650.8%0.650.8%
Usd Price Per Share83.51-65.94-32.32-27.74-27.74-
Price to Earnings Ratio-43.64--40.97--14.06--14.77--14.77-
Price-to-Total Gains Ratio-1,089.19--265.10--69.30--121.62--121.62-
Price to Book Ratio9.35-7.31-6.69-4.18-4.18-
Price-to-Total Gains Ratio-1,089.19--265.10--69.30--121.62--121.62-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share85.85
Number of shares11
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.380.09
Usd Book Value Change Per Share1.000.56
Usd Total Gains Per Share1.380.65
Gains per Quarter (11 shares)15.167.18
Gains per Year (11 shares)60.6428.72
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
117445142519
2338811284948
350132173127477
4661762341798106
58322129521123135
69926535625147164
711630941729172193
813235347833197222
914939753937221251
1016544160042246280

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%1.011.00.08.3%1.015.00.06.3%1.015.00.06.3%1.015.00.06.3%
Book Value Change Per Share2.02.00.050.0%5.07.00.041.7%5.09.02.031.3%5.09.02.031.3%5.09.02.031.3%
Dividend per Share1.00.03.025.0%2.00.010.016.7%2.00.014.012.5%2.00.014.012.5%2.00.014.012.5%
Total Gains per Share2.02.00.050.0%5.07.00.041.7%5.09.02.031.3%5.09.02.031.3%5.09.02.031.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Arcellx Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0771.003-108%0.138-156%0.558-114%0.558-114%
Book Value Per Share--8.9329.025-1%4.940+81%3.904+129%3.904+129%
Current Ratio--4.2865.452-21%3.640+18%5.827-26%5.827-26%
Debt To Asset Ratio--0.3690.3700%0.489-25%0.872-58%0.872-58%
Debt To Equity Ratio--0.5840.590-1%1.003-42%0.443+32%0.443+32%
Dividend Per Share---0.375-100%-0%0.094-100%0.094-100%
Enterprise Value--4808141197.0003869397281.000+24%1904976490.500+152%2405887188.636+100%2405887188.636+100%
Eps---0.478-0.187-61%-0.599+25%-0.464-3%-0.464-3%
Ev To Ebitda Ratio---49.679-54.758+10%-15.822-68%-27.542-45%-27.542-45%
Ev To Sales Ratio--46.17928.752+61%infnan%infnan%infnan%
Free Cash Flow Per Share--0.5260.017+3074%0.483+9%-0.038+107%-0.038+107%
Free Cash Flow To Equity Per Share--0.4400.805-45%0.907-52%0.742-41%0.742-41%
Gross Profit Margin--1.0001.031-3%1.0000%1.008-1%1.008-1%
Intrinsic Value_10Y_max--5.658--------
Intrinsic Value_10Y_min--4.716--------
Intrinsic Value_1Y_max--0.129--------
Intrinsic Value_1Y_min--0.127--------
Intrinsic Value_3Y_max--0.722--------
Intrinsic Value_3Y_min--0.682--------
Intrinsic Value_5Y_max--1.716--------
Intrinsic Value_5Y_min--1.564--------
Market Cap4642312995.000+3%4515778197.0003565550531.250+27%1747829490.750+158%1500268754.813+201%1500268754.813+201%
Net Profit Margin---0.994-0.464-53%-1.452+46%-0.479-52%-0.479-52%
Operating Margin---0.981-0.445-55%-1.589+62%-0.508-48%-0.508-48%
Operating Ratio--2.2911.684+36%2.472-7%1.039+121%1.039+121%
Pb Ratio9.611+3%9.3497.308+28%6.693+40%4.176+124%4.176+124%
Pe Ratio-44.867-3%-43.644-40.971-6%-14.056-68%-14.769-66%-14.769-66%
Price Per Share85.850+3%83.51065.938+27%32.323+158%27.744+201%27.744+201%
Price To Free Cash Flow Ratio40.824+3%39.7112.612+1420%-13.368+134%-4.651+112%-4.651+112%
Price To Total Gains Ratio-1119.709-3%-1089.189-265.095-76%-69.297-94%-121.619-89%-121.619-89%
Quick Ratio--7.2268.902-19%5.505+31%8.489-15%8.489-15%
Return On Assets---0.034-0.014-59%-0.067+100%-0.108+219%-0.108+219%
Return On Equity---0.054-0.021-61%-0.127+137%-0.077+43%-0.077+43%
Total Gains Per Share---0.0771.378-106%0.138-156%0.653-112%0.653-112%
Usd Book Value--483018000.000488033750.000-1%267116500.000+81%211122625.000+129%211122625.000+129%
Usd Book Value Change Per Share---0.0771.003-108%0.138-156%0.558-114%0.558-114%
Usd Book Value Per Share--8.9329.025-1%4.940+81%3.904+129%3.904+129%
Usd Dividend Per Share---0.375-100%-0%0.094-100%0.094-100%
Usd Eps---0.478-0.187-61%-0.599+25%-0.464-3%-0.464-3%
Usd Free Cash Flow--28429000.000895750.000+3074%26098500.000+9%-2044750.000+107%-2044750.000+107%
Usd Free Cash Flow Per Share--0.5260.017+3074%0.483+9%-0.038+107%-0.038+107%
Usd Free Cash Flow To Equity Per Share--0.4400.805-45%0.907-52%0.742-41%0.742-41%
Usd Market Cap4642312995.000+3%4515778197.0003565550531.250+27%1747829490.750+158%1500268754.813+201%1500268754.813+201%
Usd Price Per Share85.850+3%83.51065.938+27%32.323+158%27.744+201%27.744+201%
Usd Profit---25867000.000-10105750.000-61%-32299250.000+25%-24982062.500-3%-24982062.500-3%
Usd Revenue--26030000.00038954500.000-33%11792750.000+121%12686812.500+105%12686812.500+105%
Usd Total Gains Per Share---0.0771.378-106%0.138-156%0.653-112%0.653-112%
 EOD+4 -4MRQTTM+12 -27YOY+24 -115Y+15 -2310Y+15 -23

3.3 Fundamental Score

Let's check the fundamental score of Arcellx Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-44.867
Price to Book Ratio (EOD)Between0-19.611
Net Profit Margin (MRQ)Greater than0-0.994
Operating Margin (MRQ)Greater than0-0.981
Quick Ratio (MRQ)Greater than17.226
Current Ratio (MRQ)Greater than14.286
Debt to Asset Ratio (MRQ)Less than10.369
Debt to Equity Ratio (MRQ)Less than10.584
Return on Equity (MRQ)Greater than0.15-0.054
Return on Assets (MRQ)Greater than0.05-0.034
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Arcellx Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.697
Ma 20Greater thanMa 5092.684
Ma 50Greater thanMa 10088.287
Ma 100Greater thanMa 20077.702
OpenGreater thanClose89.240
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Arcellx Inc

Arcellx, Inc., together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States. The company's lead ddCAR product candidate is anitocabtagene autoleucel, which is in phase 2 clinical trial for the treatment of patients with relapsed or refractory multiple myeloma (rrMM). It also develops ACLX-001, a product candidate in Phase 1 clinical trials targeting BCMA to treat rrMM; and ACLX-002, which is in Phase 1 clinical trials that targets CD123 for treating relapsed or refractory acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). In addition, the company's preclinical product includes ACLX-003 for the treatment of AML and MDS. Further, it focuses on the development of product candidates for solid tumor programs. It has a strategic alliance with Kite Pharma, Inc. to co-develop and co-commercialize anitocabtagene autoleucel. The company was formerly known as Encarta Therapeutics, Inc. and changed its name to Arcellx, Inc. in January 2016. Arcellx, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Fundamental data was last updated by Penke on 2024-12-04 06:19:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Arcellx earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Arcellx to the Biotechnology industry mean.
  • A Net Profit Margin of -99.4% means that $-0.99 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Arcellx Inc:

  • The MRQ is -99.4%. The company is making a huge loss. -2
  • The TTM is -46.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-99.4%TTM-46.4%-53.0%
TTM-46.4%YOY-145.2%+98.7%
TTM-46.4%5Y-47.9%+1.5%
5Y-47.9%10Y-47.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-99.4%-112.2%+12.8%
TTM-46.4%-221.4%+175.0%
YOY-145.2%-210.0%+64.8%
5Y-47.9%-342.2%+294.3%
10Y-47.9%-464.5%+416.6%
4.3.1.2. Return on Assets

Shows how efficient Arcellx is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Arcellx to the Biotechnology industry mean.
  • -3.4% Return on Assets means that Arcellx generated $-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Arcellx Inc:

  • The MRQ is -3.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.4%TTM-1.4%-2.0%
TTM-1.4%YOY-6.7%+5.3%
TTM-1.4%5Y-10.8%+9.4%
5Y-10.8%10Y-10.8%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.4%-11.3%+7.9%
TTM-1.4%-11.7%+10.3%
YOY-6.7%-11.3%+4.6%
5Y-10.8%-12.7%+1.9%
10Y-10.8%-14.1%+3.3%
4.3.1.3. Return on Equity

Shows how efficient Arcellx is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Arcellx to the Biotechnology industry mean.
  • -5.4% Return on Equity means Arcellx generated $-0.05 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Arcellx Inc:

  • The MRQ is -5.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -2.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.4%TTM-2.1%-3.3%
TTM-2.1%YOY-12.7%+10.6%
TTM-2.1%5Y-7.7%+5.6%
5Y-7.7%10Y-7.7%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.4%-14.2%+8.8%
TTM-2.1%-15.9%+13.8%
YOY-12.7%-14.3%+1.6%
5Y-7.7%-18.5%+10.8%
10Y-7.7%-19.3%+11.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Arcellx Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Arcellx is operating .

  • Measures how much profit Arcellx makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Arcellx to the Biotechnology industry mean.
  • An Operating Margin of -98.1% means the company generated $-0.98  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Arcellx Inc:

  • The MRQ is -98.1%. The company is operating very inefficient. -2
  • The TTM is -44.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-98.1%TTM-44.5%-53.6%
TTM-44.5%YOY-158.9%+114.4%
TTM-44.5%5Y-50.8%+6.4%
5Y-50.8%10Y-50.8%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-98.1%-222.9%+124.8%
TTM-44.5%-310.7%+266.2%
YOY-158.9%-223.5%+64.6%
5Y-50.8%-387.1%+336.3%
10Y-50.8%-498.5%+447.7%
4.3.2.2. Operating Ratio

Measures how efficient Arcellx is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 2.29 means that the operating costs are $2.29 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Arcellx Inc:

  • The MRQ is 2.291. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.684. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.291TTM1.684+0.608
TTM1.684YOY2.472-0.788
TTM1.6845Y1.039+0.645
5Y1.03910Y1.0390.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2912.465-0.174
TTM1.6843.253-1.569
YOY2.4723.298-0.826
5Y1.0394.788-3.749
10Y1.0396.494-5.455
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Arcellx Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Arcellx is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.29 means the company has $4.29 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Arcellx Inc:

  • The MRQ is 4.286. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.452. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.286TTM5.452-1.165
TTM5.452YOY3.640+1.811
TTM5.4525Y5.827-0.376
5Y5.82710Y5.8270.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.2863.637+0.649
TTM5.4523.890+1.562
YOY3.6404.666-1.026
5Y5.8275.953-0.126
10Y5.8276.277-0.450
4.4.3.2. Quick Ratio

Measures if Arcellx is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Arcellx to the Biotechnology industry mean.
  • A Quick Ratio of 7.23 means the company can pay off $7.23 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Arcellx Inc:

  • The MRQ is 7.226. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 8.902. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ7.226TTM8.902-1.676
TTM8.902YOY5.505+3.397
TTM8.9025Y8.489+0.414
5Y8.48910Y8.4890.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.2263.086+4.140
TTM8.9023.451+5.451
YOY5.5054.456+1.049
5Y8.4895.931+2.558
10Y8.4896.436+2.053
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Arcellx Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Arcellx assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Arcellx to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.37 means that Arcellx assets are financed with 36.9% credit (debt) and the remaining percentage (100% - 36.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Arcellx Inc:

  • The MRQ is 0.369. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.370. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.369TTM0.370-0.001
TTM0.370YOY0.489-0.119
TTM0.3705Y0.872-0.502
5Y0.87210Y0.8720.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3690.350+0.019
TTM0.3700.344+0.026
YOY0.4890.310+0.179
5Y0.8720.365+0.507
10Y0.8720.382+0.490
4.5.4.2. Debt to Equity Ratio

Measures if Arcellx is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Arcellx to the Biotechnology industry mean.
  • A Debt to Equity ratio of 58.4% means that company has $0.58 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Arcellx Inc:

  • The MRQ is 0.584. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.590. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.584TTM0.590-0.007
TTM0.590YOY1.003-0.413
TTM0.5905Y0.443+0.147
5Y0.44310Y0.4430.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5840.394+0.190
TTM0.5900.432+0.158
YOY1.0030.380+0.623
5Y0.4430.451-0.008
10Y0.4430.490-0.047
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Arcellx generates.

  • Above 15 is considered overpriced but always compare Arcellx to the Biotechnology industry mean.
  • A PE ratio of -43.64 means the investor is paying $-43.64 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Arcellx Inc:

  • The EOD is -44.867. Based on the earnings, the company is expensive. -2
  • The MRQ is -43.644. Based on the earnings, the company is expensive. -2
  • The TTM is -40.971. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-44.867MRQ-43.644-1.223
MRQ-43.644TTM-40.971-2.673
TTM-40.971YOY-14.056-26.915
TTM-40.9715Y-14.769-26.202
5Y-14.76910Y-14.7690.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-44.867-2.253-42.614
MRQ-43.644-2.411-41.233
TTM-40.971-3.149-37.822
YOY-14.056-3.274-10.782
5Y-14.769-6.143-8.626
10Y-14.769-6.785-7.984
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Arcellx Inc:

  • The EOD is 40.824. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 39.711. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 2.612. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD40.824MRQ39.711+1.113
MRQ39.711TTM2.612+37.099
TTM2.612YOY-13.368+15.980
TTM2.6125Y-4.651+7.264
5Y-4.65110Y-4.6510.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD40.824-3.009+43.833
MRQ39.711-3.259+42.970
TTM2.612-3.730+6.342
YOY-13.368-4.574-8.794
5Y-4.651-8.371+3.720
10Y-4.651-9.287+4.636
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Arcellx is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 9.35 means the investor is paying $9.35 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Arcellx Inc:

  • The EOD is 9.611. Based on the equity, the company is overpriced. -1
  • The MRQ is 9.349. Based on the equity, the company is overpriced. -1
  • The TTM is 7.308. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD9.611MRQ9.349+0.262
MRQ9.349TTM7.308+2.041
TTM7.308YOY6.693+0.615
TTM7.3085Y4.176+3.132
5Y4.17610Y4.1760.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD9.6111.979+7.632
MRQ9.3492.051+7.298
TTM7.3082.365+4.943
YOY6.6932.455+4.238
5Y4.1763.726+0.450
10Y4.1764.378-0.202
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Arcellx Inc.

4.8.1. Institutions holding Arcellx Inc

Institutions are holding 94.928% of the shares of Arcellx Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30FMR Inc11.98210.03296479273-8061-0.1243
2024-09-30Paradigm Biocapital Advisors LP7.397211.300740000001519053.9475
2024-09-30Perceptive Advisors LLC7.19136.87033888669-1070-0.0275
2024-09-30NEA Management Company, LLC6.926117.0393374526200
2024-06-30BlackRock Inc6.50280.0044351636445029614.6864
2024-09-30Vanguard Group Inc4.55310.003724620961659017.225
2024-09-30SR ONE CAPITAL MANAGEMENT, LP4.339639.2928234663000
2024-09-30HHG PLC3.72070.08620119501093325.7464
2024-09-30T. Rowe Price Associates, Inc.3.51480.0183190061126992116.5526
2024-09-30RA Capital Management, LLC3.42391.7826185147924746515.4279
2024-09-30State Street Corp2.8570.00531544939-210725-12.0026
2024-09-30Cormorant Asset Management, LLC2.31165.53561250000-275000-18.0328
2024-09-30Geode Capital Management, LLC1.8030.0066974967397814.2538
2024-09-30T. Rowe Price Investment Management,Inc.1.74690.0476944638-229153-19.5225
2024-09-30Lord, Abbett & Co LLC1.64930.2426891848-855840-48.9698
2024-09-30Morgan Stanley - Brokerage Accounts1.40020.0046757152-333002-30.5463
2024-09-30Suvretta Capital Management, LLC1.27591.8435689950-826304-54.4964
2024-09-30Vestal Point Capital LP1.24834.274967500000
2024-06-30Great Point Partners LLC0.90995.201749200019200064
2024-06-30Deutsche Bank AG0.82580.0111446530-1253-0.2798
Total 75.579593.604540869358-1113807-2.7%

4.9.2. Funds holding Arcellx Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-10-31Vanguard Total Stock Mkt Idx Inv2.51950.00661362389-6694-0.4889
2024-11-27iShares Russell 2000 ETF2.230.13321205874-2520-0.2085
2024-09-30Fidelity Select Biotechnology2.1331.94561153391-115699-9.1167
2024-09-30Fidelity Growth Compy Commingled Pl S1.42160.072376873344500.5822
2024-09-30T. Rowe Price Health Sciences1.40070.409275744717255429.5018
2024-11-27SPDR® S&P Biotech ETF1.12960.7331610849-18540-2.9457
2024-10-31Vanguard Institutional Extnd Mkt Idx Tr1.05510.0443570533-2109-0.3683
2024-09-30Fidelity Growth Company Fund1.03350.0708558859-1187-0.2119
2024-08-31Fidelity Small Cap Growth1.00040.4858540965-1416-0.2611
2024-09-30T. Rowe Price New Horizons0.9330.1979504493-1590-0.3142
2024-09-30US Small-Cap Growth II Equity Comp0.9330.1979504493370067.9159
2024-09-30Janus Henderson Global Life Sciences0.89550.7071484239-6596-1.3438
2024-09-30Janus Henderson Global Life Sciences D0.89550.7094484239-6257-1.2756
2024-09-30Lord Abbett Developing Growth A0.84671.5345783800
2024-08-31Fidelity Small Cap Index0.81610.1112441286-11236-2.483
2024-09-30Fidelity Select Health Care0.73970.429340000000
2024-11-27iShares Russell 2000 Growth ETF0.72080.259638979600
2024-09-30Janus Global Life Science AUSD0.66460.702535940730180.8468
2024-08-31Fidelity Series Small Cap Opps0.65670.4299355100-15400-4.1565
2024-10-31Janus Henderson Glb Life Scn I2 USD0.650.7068351495-7912-2.2014
Total 22.6759.882512261426+19872+0.2%

5.3. Insider Transactions

Insiders are holding 12.623% of the shares of Arcellx Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-11-11Kavita PatelSELL15238105.92
2024-11-08Kavita PatelSELL33763104.14
2024-10-22Kavita PatelSELL150089.69
2024-09-17Michelle GilsonSELL1500077.73
2024-09-10Kavita PatelSELL150074.41
2024-09-05Christopher HeerySELL342170.02
2024-09-03Christopher HeerySELL2745167.03
2024-08-26Christopher HeerySELL2168471.12
2024-07-30Kavita PatelSELL150061.97
2024-07-16Christopher HeerySELL1090165.3
2024-07-11Christopher HeerySELL367160.01
2024-07-09Kavita PatelSELL150056.63
2024-07-01Christopher HeerySELL2000055.39
2024-06-27Kavita PatelSELL1000054.27
2024-06-26Michelle GilsonSELL1287753.7
2024-06-12Christopher HeerySELL2000055.13
2024-05-24Michelle GilsonSELL1212150.71
2024-05-01Christopher HeerySELL1816851.33
2024-04-16Olivia C. WareSELL940255.55
2024-04-01Rami ElghandourSELL2308667.09
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets764,909
Total Liabilities281,891
Total Stockholder Equity483,018
 As reported
Total Liabilities 281,891
Total Stockholder Equity+ 483,018
Total Assets = 764,909

Assets

Total Assets764,909
Total Current Assets587,301
Long-term Assets177,608
Total Current Assets
Cash And Cash Equivalents 161,846
Short-term Investments 412,408
Net Receivables 3,400
Other Current Assets 9,647
Total Current Assets  (as reported)587,301
Total Current Assets  (calculated)587,301
+/-0
Long-term Assets
Property Plant Equipment 71,431
Long Term Investments 102,428
Long-term Assets  (as reported)177,608
Long-term Assets  (calculated)173,859
+/- 3,749

Liabilities & Shareholders' Equity

Total Current Liabilities137,017
Long-term Liabilities144,874
Total Stockholder Equity483,018
Total Current Liabilities
Short-term Debt 18,118
Accounts payable 5,989
Other Current Liabilities 112,910
Total Current Liabilities  (as reported)137,017
Total Current Liabilities  (calculated)137,017
+/-0
Long-term Liabilities
Capital Lease Obligations 65,332
Long-term Liabilities Other 15,048
Long-term Liabilities  (as reported)144,874
Long-term Liabilities  (calculated)80,380
+/- 64,494
Total Stockholder Equity
Common Stock53
Retained Earnings -449,747
Accumulated Other Comprehensive Income 1,899
Other Stockholders Equity 930,813
Total Stockholder Equity (as reported)483,018
Total Stockholder Equity (calculated)483,018
+/-0
Other
Capital Stock53
Cash and Short Term Investments 574,254
Common Stock Shares Outstanding 53,822
Liabilities and Stockholders Equity 764,909
Net Debt -96,514
Net Invested Capital 483,018
Net Working Capital 450,284
Property Plant and Equipment Gross 71,431
Short Long Term Debt Total 65,332



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-31
> Total Assets 
57,694
0
0
144,963
128,782
243,390
375,326
337,327
313,817
622,943
623,528
614,218
825,132
779,695
734,306
764,909
764,909734,306779,695825,132614,218623,528622,943313,817337,327375,326243,390128,782144,9630057,694
   > Total Current Assets 
49,357
0
0
134,139
112,809
220,903
325,747
290,305
266,863
571,367
558,070
491,456
716,363
588,733
530,203
587,301
587,301530,203588,733716,363491,456558,070571,367266,863290,305325,747220,903112,809134,1390049,357
       Cash And Cash Equivalents 
46,596
0
0
70,027
104,617
127,160
164,540
56,763
64,179
274,892
303,665
126,119
394,583
154,782
100,233
161,846
161,846100,233154,782394,583126,119303,665274,89264,17956,763164,540127,160104,61770,0270046,596
       Short-term Investments 
0
0
0
61,155
73,784
83,769
142,446
224,018
190,656
258,701
202,819
313,597
307,434
419,345
416,663
412,408
412,408416,663419,345307,434313,597202,819258,701190,656224,018142,44683,76973,78461,155000
       Net Receivables 
0
0
0
0
0
0
0
0
0
21,230
29,431
31,480
0
3,100
3,200
3,400
3,4003,2003,100031,48029,43121,230000000000
       Other Current Assets 
1,210
0
0
1,649
2,049
9,974
3,191
9,524
12,028
16,544
22,155
20,260
14,346
11,506
13,515
9,647
9,64713,51511,50614,34620,26022,15516,54412,0289,5243,1919,9742,0491,649001,210
   > Long-term Assets 
8,337
0
0
10,824
15,973
22,487
49,579
47,022
46,954
44,066
51,671
109,884
96,995
190,962
204,103
177,608
177,608204,103190,96296,995109,88451,67144,06646,95447,02249,57922,48715,97310,824008,337
       Property Plant Equipment 
4,900
0
0
6,781
10,318
13,375
37,109
39,003
39,890
44,066
51,671
66,924
69,827
69,126
70,341
71,431
71,43170,34169,12669,82766,92451,67144,06639,89039,00337,10913,37510,3186,781004,900
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
42,960
27,168
117,102
130,128
102,428
102,428130,128117,10227,16842,96000000000000
       Other Assets 
3,437
0
0
0
5,655
9,112
12,470
8,019
7,064
7,510
13,787
12,878
11,774
0
0
0
00011,77412,87813,7877,5107,0648,01912,4709,1125,6550003,437
> Total Liabilities 
121,414
0
0
248,758
250,297
21,799
59,370
101,043
108,863
319,226
329,861
348,090
339,752
283,122
247,142
281,891
281,891247,142283,122339,752348,090329,861319,226108,863101,04359,37021,799250,297248,75800121,414
   > Total Current Liabilities 
5,271
0
0
13,261
14,845
16,808
32,053
44,777
56,693
166,057
156,114
173,149
118,238
107,901
88,290
137,017
137,01788,290107,901118,238173,149156,114166,05756,69344,77732,05316,80814,84513,261005,271
       Short-term Debt 
0
0
0
0
0
370
2,313
30,603
35,961
40,241
44,156
54,868
46,784
39,677
52,838
18,118
18,11852,83839,67746,78454,86844,15640,24135,96130,6032,31337000000
       Accounts payable 
504
0
0
1,583
1,333
1,874
7,556
2,962
9,053
4,532
5,693
7,185
2,619
3,099
4,868
5,989
5,9894,8683,0992,6197,1855,6934,5329,0532,9627,5561,8741,3331,58300504
       Other Current Liabilities 
4,767
0
0
11,678
13,512
14,564
22,184
11,212
11,679
13,997
12,390
16,916
18,302
33,933
15,614
112,910
112,91015,61433,93318,30216,91612,39013,99711,67911,21222,18414,56413,51211,678004,767
   > Long-term Liabilities 
116,143
0
0
235,497
235,452
4,991
27,317
56,266
52,170
153,169
173,747
174,941
221,514
175,221
158,852
144,874
144,874158,852175,221221,514174,941173,747153,16952,17056,26627,3174,991235,452235,49700116,143
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
4,844
27,200
56,266
52,170
47,407
49,479
53,851
50,841
47,685
21,453
47,214
47,21421,45347,68550,84153,85149,47947,40752,17056,26627,2004,84400000
       Other Liabilities 
1,882
0
0
0
1,896
0
0
0
0
0
0
0
0
0
0
0
000000000001,8960001,882
       Long-term Liabilities Other 
19
0
0
206
178
4,991
27,317
4,624
0
153,169
173,747
0
0
15,468
14,899
15,048
15,04814,89915,46800173,747153,16904,62427,3174,9911782060019
       Deferred Long Term Liability 
1,761
0
0
0
3,172
8,913
9,969
5,518
0
0
0
0
0
0
0
0
000000005,5189,9698,9133,1720001,761
> Total Stockholder Equity
-63,720
0
0
-103,795
-121,515
221,591
315,956
236,284
204,954
303,717
293,667
266,128
485,380
496,573
487,164
483,018
483,018487,164496,573485,380266,128293,667303,717204,954236,284315,956221,591-121,515-103,79500-63,720
   Common Stock
1
0
0
1
1
36
44
44
44
48
48
48
52
53
53
53
535353524848484444443611001
   Retained Earnings -449,747-423,880-396,678-389,480-409,324-369,988-346,134-318,790-279,798-194,587-162,496-130,111-109,44100-65,142
   Capital Surplus 
0
0
0
0
0
384,095
510,761
384,095
0
649,717
663,614
0
0
0
0
0
00000663,614649,7170384,095510,761384,09500000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
1,421
0
0
5,650
8,615
137,111
510,761
179,110
523,921
649,717
663,607
675,404
874,261
893,710
911,783
930,813
930,813911,783893,710874,261675,404663,607649,717523,921179,110510,761137,1118,6155,650001,421



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue110,319
Cost of Revenue-2,040
Gross Profit110,319108,279
 
Operating Income (+$)
Gross Profit110,319
Operating Expense-200,199
Operating Income-89,880-89,880
 
Operating Expense (+$)
Research Development133,849
Selling General Administrative66,350
Selling And Marketing Expenses2,040
Operating Expense200,199202,239
 
Net Interest Income (+$)
Interest Income19,379
Interest Expense-3,842
Other Finance Cost-139
Net Interest Income15,398
 
Pretax Income (+$)
Operating Income-89,880
Net Interest Income15,398
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-70,027-109,733
EBIT - interestExpense = -70,027
-70,027
-66,848
Interest Expense3,842
Earnings Before Interest and Taxes (EBIT)-66,185-66,185
Earnings Before Interest and Taxes (EBITDA)-64,145
 
After tax Income (+$)
Income Before Tax-70,027
Tax Provision-663
Net Income From Continuing Ops-129,526-70,690
Net Income-70,690
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses200,199
Total Other Income/Expenses Net19,853-15,398
 

Technical Analysis of Arcellx
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Arcellx. The general trend of Arcellx is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Arcellx's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Arcellx Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 107.37.

The bearish price targets are: 83.69 > 77.00 > 75.10.

Tweet this
Arcellx Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Arcellx Inc. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Arcellx Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Arcellx Inc. The current macd is -0.00818319.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Arcellx price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Arcellx. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Arcellx price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Arcellx Inc Daily Moving Average Convergence/Divergence (MACD) ChartArcellx Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Arcellx Inc. The current adx is 13.88.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Arcellx shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Arcellx Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Arcellx Inc. The current sar is 84.43.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Arcellx Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Arcellx Inc. The current rsi is 44.70. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Arcellx Inc Daily Relative Strength Index (RSI) ChartArcellx Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Arcellx Inc. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Arcellx price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Arcellx Inc Daily Stochastic Oscillator ChartArcellx Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Arcellx Inc. The current cci is -81.94605879.

Arcellx Inc Daily Commodity Channel Index (CCI) ChartArcellx Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Arcellx Inc. The current cmo is -17.28001573.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Arcellx Inc Daily Chande Momentum Oscillator (CMO) ChartArcellx Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Arcellx Inc. The current willr is -87.02313007.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Arcellx Inc Daily Williams %R ChartArcellx Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Arcellx Inc.

Arcellx Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Arcellx Inc. The current atr is 5.27196468.

Arcellx Inc Daily Average True Range (ATR) ChartArcellx Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Arcellx Inc. The current obv is 21,861,671.

Arcellx Inc Daily On-Balance Volume (OBV) ChartArcellx Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Arcellx Inc. The current mfi is 27.41.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Arcellx Inc Daily Money Flow Index (MFI) ChartArcellx Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Arcellx Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-19MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-23MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-24STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-25MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-05STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-23STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-09-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-09-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-18STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-19ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-20STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-24MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-09-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-10-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-10-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-16BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-11-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Arcellx Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Arcellx Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.697
Ma 20Greater thanMa 5092.684
Ma 50Greater thanMa 10088.287
Ma 100Greater thanMa 20077.702
OpenGreater thanClose89.240
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Arcellx with someone you think should read this too:
  • Are you bullish or bearish on Arcellx? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Arcellx? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Arcellx Inc

I send you an email if I find something interesting about Arcellx Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Arcellx Inc.

Receive notifications about Arcellx Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.